[--[65.84.65.76]--]
BIOCON
BIOCON LIMITED.

276.95 3.06 (1.12%)

Related News for BIOCON

F&O stocks: Infosys, Biocon among 5 stocks with short buildup

 01 Mar 01:22 PM

When a trader is expecting the stock prices to fall, he may sell the stock without owning that and buy at a lower price, for example, stock XYZ is trading at 100, a trader sells the stocks at Rs 100 and buys it back at Rs 90.

Biocon shares gain on licence deal with Janssen, JJ for US markets

 01 Mar 09:42 AM

Biocon Share Price | In an another development, the company's subsidiary received observations from US Food and Drug Administration (USFDA).

F&O stocks to buy today: SBI Life, Biocon among top 3 trading ideas for 1 March 2024

 01 Mar 09:28 AM

Positive setup was seen in stocks like Berger Paint, Hindustan Copper, Indus Tower, MCX, Ambuja Cement, Persistent, Indian Hotel, United Spirits, Persistent, Concor, Siemens, TVS Motor etc. among others.

Buzzing Stocks: Adani Enterprises, Biocon, Vedanta, ICICI Bank, LT, HCL Tech and others in news

 01 Mar 06:00 AM

Stocks to watch: Check out the companies making headlines before the opening bell today, on March 01, 2024.

Biocon Biologics inks licence pact with Janssen for biosimilar product

 29 Feb 09:39 PM

The agreement licenses the company to launch in the US in February 2025, once approved by the US Food and Drug Administration(USFDA), Biocon Biologics said in a statement.

BIOCON: BIOCON BIOLOGICS SECURES US MARKET ENTRY DATE FOR BMAB 1200, A PROPOSED BIOSIMILAR TO STELARA || AGREEMENT LICENSES COMPANY TO LAUNCH IN UNITED STATES, IN FEBRUARY 2025, ONCE APPROVED BY U.S. FDA

 29 Feb 06:55 PM

BIOCON: BIOCON BIOLOGICS SECURES US MARKET ENTRY DATE FOR BMAB 1200, A PROPOSED BIOSIMILAR TO STELARA || AGREEMENT LICENSES COMPANY TO LAUNCH IN UNITED STATES, IN FEBRUARY 2025, ONCE APPROVED BY U.S. FDA

US FDA issues 4 observations for Biocon Biologics' insulin facility

 29 Feb 05:53 PM

The trigger for this inspection was a Pre-Approval Supplement (PAS) filed by BBL's customer late last year

BIOCON: CO WILL SUBMIT A COMPREHENSIVE CORRECTIVE AND PREVENTIVE ACTION (CAPA) PLAN TO U.S. FDA || OUTCOME OF INSPECTION DOES NOT IMPACT MANUFACTURING, DISTRIBUTION OF CO'S PRODUCTS IN US MARKET

 29 Feb 04:51 PM

BIOCON: CO WILL SUBMIT A COMPREHENSIVE CORRECTIVE AND PREVENTIVE ACTION (CAPA) PLAN TO U.S. FDA || OUTCOME OF INSPECTION DOES NOT IMPACT MANUFACTURING, DISTRIBUTION OF CO'S PRODUCTS IN US MARKET

BIOCON: CO SAYS U.S. FDA CONDUCTED INSPECTION AT BIOCON BIOLOGICS'S BIOCON CAMPUS (SITE 1) FACILITY BETWEEN FEBRUARY 20-28 || AGENCY HAS ISSUED FORM 483S WITH 4 OBSERVATIONS

 29 Feb 04:50 PM

BIOCON: CO SAYS U.S. FDA CONDUCTED INSPECTION AT BIOCON BIOLOGICS'S BIOCON CAMPUS (SITE 1) FACILITY BETWEEN FEBRUARY 20-28 || AGENCY HAS ISSUED FORM 483S WITH 4 OBSERVATIONS

F&O Ban List: Canara Bank, SAIL among 5 stocks under trade ban on Tuesday

 27 Feb 11:50 AM

Ashok Leyland, Biocon, GMR Airports Infrastructure, Gujarat Narmada Valley Fertilizers and Chemicals (GNFC), Hindustan Copper, Piramal Enterprises, PVR Inox, RBL Bank have moved out of the ban.